Profound Medical PROF Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $5.34M+104% | $5.98M+43.1% | $5.29M+86.8% | $2.21M-1.0% | $2.62M+82.1% | ||
| $1.51M+96.0% | $1.99M+63.6% | $1.36M+30.1% | $593K-27.0% | $768K+34.0% | ||
| $3.83M+107% | $3.99M+34.7% | $3.93M+120% | $1.62M+13.9% | $1.85M+114% | ||
| 71.8%+1.1pp | 66.8%-4.2pp | 74.3%+11.2pp | 73.2%+9.5pp | 70.7%+10.5pp | ||
| $5.26M+9.4% | $4.27M-8.1% | $5.42M+30.1% | $6.1M+45.0% | $4.81M+21.9% | ||
| $6.59M-19.7% | $7.09M+6.5% | $7.43M+12.2% | $9.33M+84.4% | $8.21M+71.1% | ||
| $11.85M-9.0% | $11.36M+0.5% | $12.84M+19.1% | $15.42M+66.5% | $13.02M+48.9% | ||
| $11.85M-9.0% | $11.36M+0.5% | $12.84M+19.1% | $15.42M+66.5% | $13.02M+48.9% | ||
| -$8.02M+28.2% | -$7.37M+11.7% | -$8.91M+0.9% | -$13.81M-76.1% | -$11.17M-41.8% | ||
| -150.3%+276pp | -123.3%+76.5pp | -168.5%+149pp | -624.4%-273pp | -426%+121pp | ||
| $377K-15.3% | $160K-51.8% | $122K-44.5% | $343K-18.7% | $445K-3.7% | ||
| $993K+106% | -$780K-125% | $1.06M+656% | -$1.83M-294% | $483K-63.7% | ||
| -$7.03M+34.2% | -$8.15M-57.2% | -$7.86M+14.5% | -$15.63M-127% | -$10.68M-63.2% | ||
| $25K-39.0% | $26K+111% | $121K-31.6% | $64K+237% | $41K+2.5% | ||
| -$7.05M+34.2% | -$8.18M-65.3% | -$7.98M+14.8% | -$15.7M-127% | -$10.72M-62.9% | ||
| -132.2%+277pp | -136.8%-18.3pp | -150.8%+180pp | -709.9%-400pp | -409.2%+48.5pp | ||
| $0.19-47.2% | $0.27+50.0% | $0.26-31.6% | $0.52+85.7% | $0.36+33.3% | ||
| $0.19-47.2% | $0.27+50.0% | $0.26-31.6% | $0.52+85.7% | $0.36+33.3% | ||
| 36.3M+20.8% | 30.2M+22.1% | 30.1M+22.7% | 30.1M+23.0% | 30M+23.7% | ||
| 36.3M+20.8% | 30.2M+22.1% | 30.1M+22.7% | 30.1M+23.0% | 30M+23.7% | ||
| $377K-15.3% | $160K-51.8% | $122K-44.5% | $343K-18.7% | $445K-3.7% | ||
| -$8.06M+24.1% | -$7.9M-14.2% | -$8.79M0.0% | -$12.98M-75.7% | -$10.62M-40.6% | ||
| -$2K— | $14K+138% | $21K+158% | -$14K+61.6% | $0+100% | ||
| $616K+1,521% | -$940K-133% | $935K+328% | -$2.17M-517% | $38K-95.6% | ||
| -$1.01M-1,076% | $275K+114% | -$808K-238% | $2.71M+677% | $103K+111% | ||
| -$8.02M+28.2% | -$7.37M+11.7% | -$8.91M+0.9% | -$13.81M-76.1% | -$11.17M-41.8% | ||
| -$7.92M+28.0% | -$7.26M+10.4% | -$8.77M+0.2% | -$13.67M-79.6% | -$11M-44.3% | ||
| -$7.92M+28.0% | -$7.26M+10.4% | -$8.77M+0.2% | -$13.67M-79.6% | -$11M-44.3% | ||
| -148.4%+271pp | -121.5%+72.7pp | -165.7%+144pp | -618%-277pp | -419.8%+110pp | ||
| -$8.02M+28.2% | -$7.37M+11.7% | -$8.91M+0.9% | -$13.81M-76.1% | -$11.17M-41.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Profound Medical's revenue?
- Profound Medical (PROF) generated $18.8M in revenue over the trailing twelve months, up 58.6% year over year.
- Is Profound Medical profitable?
- Profound Medical is not currently profitable: it reported a net loss of $38.9M over the trailing twelve months, a -206.8% net margin.
- What are Profound Medical's profit margins?
- Gross margin is 71.1% and operating margin is -202.6%, with a -206.8% net margin.
- What is Profound Medical's earnings per share?
- Profound Medical's diluted EPS over the trailing twelve months is $1.24.
- Where does Profound Medical's income statement data come from?
- Every line is extracted from Profound Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
